Hospital costs during the first 5 years of life for multiples compared with singletons born after IVF or ICSI

被引:18
|
作者
van Heesch, M. M. J. [1 ]
Evers, J. L. H. [2 ,3 ]
van der Hoeven, M. A. H. B. M. [4 ]
Dumoulin, J. C. M. [2 ,3 ]
van Beijsterveldt, C. E. M. [5 ]
Bonsel, G. J. [6 ,7 ,8 ]
Dykgraaf, R. H. M. [9 ]
van Goudoever, J. B. [10 ,11 ]
Koopman-Esseboom, C. [12 ]
Nelen, W. L. D. M. [13 ]
Steiner, K. [14 ]
Tamminga, P. [15 ]
Tonch, N. [16 ]
Torrance, H. L. [17 ]
Dirksen, C. D. [1 ]
机构
[1] Maastricht Univ Med Ctr, Dept Clin Epidemiol & Med Technol Assessment, POB 5800, NL-6202 AZ Maastricht, Netherlands
[2] Maastricht Univ Med Ctr, Dept Obstet & Gynecol, NL-6202 AZ Maastricht, Netherlands
[3] Maastricht Univ Med Ctr, Sch Oncol & Dev Biol, GROW, NL-6202 AZ Maastricht, Netherlands
[4] Maastricht Univ Med Ctr, Dept Neonatol, NL-6202 AZ Maastricht, Netherlands
[5] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands
[6] Erasmus MC, Dept Obstet & Prenatal Med, NL-3000 CA Rotterdam, CA, Netherlands
[7] Midwifery Acad Rotterdam, NL-3015 EK Rotterdam, Netherlands
[8] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands
[9] Erasmus MC, Dept Obstet & Gynecol, NL-3000 CA Rotterdam, Netherlands
[10] Acad Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1100 DD Amsterdam, Netherlands
[11] Vrije Univ Amsterdam Med Ctr, Dept Pediat, NL-1007 MB Amsterdam, Netherlands
[12] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, NL-3508 AB Utrecht, Netherlands
[13] Radboud Univ Nijmegen Med Ctr, Dept Obstet & Gynecol, NL-6500 HB Nijmegen, Netherlands
[14] Radboud Univ Nijmegen Med Ctr, Dept Neonatol, NL-6500 HB Nijmegen, Netherlands
[15] Acad Med Ctr, Emma Childrens Hosp, Dept Neonatol, NL-1100 DD Amsterdam, Netherlands
[16] Acad Med Ctr, Ctr Reprod Med, NL-1100 DD Amsterdam, Netherlands
[17] Univ Med Ctr Utrecht, Dept Reprod Med, NL-3508 AB Utrecht, Netherlands
关键词
assisted reproduction; multiple pregnancy; child follow-up; hospital costs; ASSISTED REPRODUCTIVE TECHNOLOGY; IN-VITRO FERTILIZATION; DANISH NATIONAL COHORT; PRETERM BIRTH; CARE UTILIZATION; EMBRYO-TRANSFER; CHILDREN BORN; INFANTS; RISK; PREGNANCIES;
D O I
10.1093/humrep/dev059
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
STUDY QUESTION: Do in vitro fertilization (IVF) multiples generate higher hospital costs than IVF singletons, from birth up to age 5? SUMMARY ANSWER: Hospital costs from birth up to age 5 were significantly higher among IVF/ICSI multiple children compared with IVF/ICSI singletons; however, when excluding the costs incurred during the birth admission period, hospital costs of multiples and singletons were comparable. WHAT IS KNOWN ALREADY: Concern has risen over the long-term outcome of children born after IVF. The increased incidence of multiple births in IVF as a result of double-embryo transfer predisposes children to a poorer neonatal outcome such as preterm birth and low birth-weight. As a consequence, IVF multiples require more medical care. Costs and consequences of poorer neonatal outcomes in multiples may also exist later in life. STUDY DESIGN, SIZE, DURATION: All 5497 children born from IVF in 2003-2005, whose parents received IVF or ICSI treatment in one of five participating Dutch IVF centers, served as a basis for a retrospective cohort study. Based on gestational age, birthweight, Apgar and congenital malformation, children were assigned to one of three risk strata (low-, moderate-or high-risk). PARTICIPANTS/MATERIALS, SETTING, METHODS: To enhance the efficiency of the data collection, 816 multiples and 584 singletons were selected for 5-year follow-up based on stratified (risk) sampling. Parental informed consent was received of 322 multiples and 293 singletons. Individual-level hospital resource use data (hospitalization, outpatient visits and medical procedures) were retrieved from hospital information systems and patient charts for 302 multiples and 278 singletons. MAIN RESULTS AND THE ROLE OF CHANCE: The risk of hospitalization (OR 4.9, 95% CI 3.3-7.0), outpatient visits (OR 2.6, 95% CI 1.8-3.6) and medical procedures (OR 1.7, 95% CI 1.2-2.2) was higher for multiples compared with singletons. The average hospital costs amounted to (sic)10 018 and (sic)2093 during the birth admission period (P < 0.001), (sic)1131 and (sic)696 after the birth admission period to the first birthday (not significant (n.s.)) and (sic)1084 and (sic)938 from the second to the fifth life year (n.s.) for multiples and singletons, respectively. Hospital costs from birth up to age 5 were 3.3-fold higher for multiples compared with singletons (P < 0.001). Among multiples and singletons, respectively, 90.8 and 76.2% of the total hospital costs were caused by hospital admission days and 8.9 and 25.2% of the total hospital costs during the first 5 years of life occurred after the first year of life. LIMITATIONS, REASONS FOR CAUTION: Resource use and costs outside the hospital were not included in the analysis. WIDER IMPLICATIONS OF THE FINDINGS: This study confirms the increased use of healthcare resources by IVF/ICSI multiples compared with IVF/ICSI singletons. Single-embryo transfer may result in substantial savings, particularly in the birth admission period. These savings need to be compared with the extra costs of additional embryo transfers needed to achieve a successful pregnancy. Besides costs, health outcomes of children born after single-embryo transfer should be compared with those born after double-embryo transfer.
引用
收藏
页码:1481 / 1490
页数:10
相关论文
共 50 条
  • [31] Nutritional status in premature infants born small by gestational age in the first 5 years of life
    Kovalenko, Tatyana
    Yuditskiy, Anton
    Petrova, Irina
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 1): : 285 - 286
  • [32] Premature infants born small to gestational age: growth dynamics in the first 5 years of life
    Yuditskiy, Anton
    Kovalenko, Tatyana
    Petrova, Irina
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 447 - 447
  • [33] EVALUATION OF THE DIRECT COSTS OF HEALTH CARE DURING THE FIRST YEAR OF LIFE OF BABIES BORN WITH MICROCEPHALY IN THE SUS
    Zanghelini, F.
    Pitta, M. G.
    Andrade, C. A.
    VALUE IN HEALTH, 2016, 19 (07) : A609 - A609
  • [34] Hematopoietic cellular aging is not accelerated during the first 2 years of life in children born preterm
    Ewa Henckel
    Mattias Landfors
    Zahra Haider
    Paraskevi Kosma
    Magnus Hultdin
    Sofie Degerman
    Kajsa Bohlin
    Pediatric Research, 2020, 88 : 903 - 909
  • [35] Decline of maternal hepatitis A antibodies during the first 2 years of life in infants born in Turkey
    Derya, A
    Necmi, A
    Emre, A
    Akgün, Y
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (02): : 457 - 459
  • [36] Hematopoietic cellular aging is not accelerated during the first 2 years of life in children born preterm
    Henckel, Ewa
    Landfors, Mattias
    Haider, Zahra
    Kosma, Paraskevi
    Hultdin, Magnus
    Degerman, Sofie
    Bohlin, Kajsa
    PEDIATRIC RESEARCH, 2020, 88 (06) : 903 - 909
  • [37] Born during the NEP years. The first five-year plan: life and destiny
    Feldman, Mikhail
    ROSSIISKAYA ISTORIYA, 2022, (04): : 172 - 185
  • [38] Healthcare Resource Utilization and Associated Costs During the First 5 Years After Diagnosis and at the End of Life: A Nationwide Cohort Study of Patients with Multiple Myeloma in Finland
    Kosunen, Mikko
    Ruotsalainen, Jarno
    Kallio, Alvar
    Metsa, Roope
    Raittinen, Paavo
    Lehmus, Leena
    Korhonen, Maarit J.
    Purmonen, Timo
    PHARMACOECONOMICS-OPEN, 2024, : 57 - 68
  • [39] Postnatal growth in children born small and appropriate for gestational age during the first years of life
    Valuniene, Margarita
    Danylaite, Agne
    Kryziute, Dovile
    Ramanauskaite, Giedre
    Lagiene, Danute
    Lasas, Liudvikas
    Verkauskiene, Rasa
    MEDICINA-LITHUANIA, 2009, 45 (01): : 51 - 60
  • [40] Longitudinal study of DNA methylation during the first 5 years of life
    Rocio G. Urdinguio
    María Isabel Torró
    Gustavo F. Bayón
    Julio Álvarez-Pitti
    Agustín F. Fernández
    Pau Redon
    Mario F. Fraga
    Empar Lurbe
    Journal of Translational Medicine, 14